The Cooper Companies Inc (COO)
90.46
+0.05
(+0.06%)
USD |
NASDAQ |
Apr 19, 16:00
90.46
0.00 (0.00%)
After-Hours: 20:00
Cooper Enterprise Value: 20.60B for April 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 18, 2024 | 20.60B |
April 17, 2024 | 20.49B |
April 16, 2024 | 20.63B |
April 15, 2024 | 20.93B |
April 12, 2024 | 21.22B |
April 11, 2024 | 21.74B |
April 10, 2024 | 21.81B |
April 09, 2024 | 22.29B |
April 08, 2024 | 22.24B |
April 05, 2024 | 22.23B |
April 04, 2024 | 22.34B |
April 03, 2024 | 22.30B |
April 02, 2024 | 22.12B |
April 01, 2024 | 22.36B |
March 28, 2024 | 22.80B |
March 27, 2024 | 22.87B |
March 26, 2024 | 22.65B |
March 25, 2024 | 22.68B |
March 22, 2024 | 22.59B |
March 21, 2024 | 22.78B |
March 20, 2024 | 22.84B |
March 19, 2024 | 22.96B |
March 18, 2024 | 22.67B |
March 15, 2024 | 22.65B |
March 14, 2024 | 22.81B |
Date | Value |
---|---|
March 13, 2024 | 22.98B |
March 12, 2024 | 22.81B |
March 11, 2024 | 22.79B |
March 08, 2024 | 22.81B |
March 07, 2024 | 22.92B |
March 06, 2024 | 22.88B |
March 05, 2024 | 22.79B |
March 04, 2024 | 23.06B |
March 01, 2024 | 22.94B |
February 29, 2024 | 21.24B |
February 28, 2024 | 21.42B |
February 27, 2024 | 21.26B |
February 26, 2024 | 21.42B |
February 23, 2024 | 21.86B |
February 22, 2024 | 22.07B |
February 21, 2024 | 22.13B |
February 20, 2024 | 21.65B |
February 16, 2024 | 21.11B |
February 15, 2024 | 21.24B |
February 14, 2024 | 21.14B |
February 13, 2024 | 20.90B |
February 12, 2024 | 21.46B |
February 09, 2024 | 21.34B |
February 08, 2024 | 21.19B |
February 07, 2024 | 21.24B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
13.68B
Minimum
Mar 23 2020
24.10B
Maximum
Apr 01 2022
19.34B
Average
19.23B
Median
Feb 18 2020
Enterprise Value Benchmarks
Integer Holdings Corp | 4.872B |
Anika Therapeutics Inc | 305.43M |
Staar Surgical Co | 2.064B |
OrthoPediatrics Corp | 630.50M |
NexGel Inc | 12.37M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 81.20M |
Revenue (Quarterly) | 931.60M |
Total Expenses (Quarterly) | 778.50M |
EPS Diluted (Quarterly) | 0.41 |
Gross Profit Margin (Quarterly) | 66.96% |
Profit Margin (Quarterly) | 8.72% |
Earnings Yield | 1.62% |
Operating Earnings Yield | 2.97% |
Normalized Earnings Yield | 1.652 |